Related Experiment Video
Updated: Jan 4, 2026
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Morfea: revisión práctica de su diagnóstico, clasificación y tratamiento
Pamela Rodríguez-Salgado1, María Teresa García-Romero1
1Instituto Nacional de Pediatría, Servicio de Dermatología, Ciudad de México, México.
Abstract:
Morphea, or localized scleroderma, is a rare disease of the connective tissue that manifests itself with localized sclerosis of the skin and, in some cases, with extracutaneous manifestations. Its etiology is not fully understood, but it is believed that there is genetic predisposition, in addition to environmental triggering factors. Classification of the disease is not simple due to its multiple presentations; however, it is useful in order to define the treatment, which should be individualized and started early to avoid cosmetic and functional complications. In this review, we summarize the most important practical aspects of the classification, diagnostic methods and evaluation of morphea activity, as well as available therapeutic options, with an emphasis on existing clinical evidence regarding their efficacy and safety.
Insights
Morphea, a rare localized scleroderma, presents skin hardening and sometimes affects other organs. Early diagnosis and individualized treatment are crucial for managing this condition and preventing complications.
Area of Science:
- Dermatology
- Rheumatology
- Connective tissue diseases
Background:
- Morphea, a subtype of localized scleroderma, is a rare connective tissue disease.
- Characterized by localized skin sclerosis, it can involve extracutaneous manifestations.
- Etiology is multifactorial, involving genetic predisposition and environmental triggers.
Purpose of the Study:
- To review practical aspects of morphea classification.
- To discuss diagnostic methods and activity evaluation.
- To summarize therapeutic options based on clinical evidence.
Main Methods:
- Literature review focusing on classification, diagnosis, and treatment of morphea.
- Emphasis on clinical evidence for efficacy and safety of therapies.
Main Results:
- Classification is complex due to varied presentations but guides individualized treatment.
- Early intervention is key to avoid cosmetic and functional sequelae.
- Various therapeutic options exist, with evidence on efficacy and safety being crucial.
Conclusions:
- Morphea management requires a tailored approach based on classification and presentation.
- Prompt diagnosis and treatment are essential for optimal outcomes.
- Further research on evidence-based therapies is ongoing.
Related Concept Videos
01:24Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
01:26Methods of Documentation II: POMR
01:26Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
01:20Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
01:30Irritable Bowel Syndrome III: Medical and Nursing Management